ArticleFrontiers in public health2025
Research on the evolution of biotechnology cooperation networks - a study based on patent data in China from 2004 to 2023.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Biotechnology has significant potential in public health, offering critical support for communicable disease control, chronic illness management, and drug development. To foster biotechnology innovation, governments increasingly incentivize cooperations among organizations, resulting in more interconnected biotechnology cooperation networks. However, research on the evolution of these networks rely primarily on static network analysis and neglect the micromechanisms under the evolution, which lead to deviations in policymaking. Methods: Using temporal exponential random graph model (TERGM), which accounts for dynamic network correlations, and based on micromechanisms framework consisting of agency, opportunity and inertia, this study analyzes the impacts of both endogenous and exogenous factors on the evolution of biotechnology cooperation networks. Results: The empirical analysis based on China's biotechnology patent data from 2004 to 2023 reveals the following findings and policy recommendations. First, the evolution of the biotechnology cooperation networks is temporally dependent, highlighting the need for awareness of policy lags. Second, two endogenous factors - transitivity and convergence - emerge in the evolution, implying the need for government to create information platforms, establish targeted project subsidies, and enforce technical confidentiality policies. Finally, with regard to exogenous factors, the networks exhibit geographical homogeneity, implying the needs for government to promote cross-regional cooperation by establishing innovation centers and unified standards to mitigate lock-in effects and barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.